My Quote Request
No products added yet
6505-01-087-8486
20 Products
NDC00597-0074-01
METAPROTERENOL SULFATE TABLETS,USP
NSN, MFG P/N
6505010878486
NSN
6505-01-087-8486
NDC00597-0074-01
METAPROTERENOL SULFATE TABLETS,USP
NSN, MFG P/N
6505010878486
NSN
6505-01-087-8486
MFG
BOEHRINGER INGELHEIM PHARMACEUTICALS INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS METAPROTERENOL SULFATE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
86200
GLUCOSE TEST SOLUTION
NSN, MFG P/N
6505010878516
NSN
6505-01-087-8516
MFG
CUSTOM LABORATORIES INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 100.000 GRAMS DEXTROSE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
FLAVOR: ORANGE
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 FLUID OUNCES
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: CAFFEINE FREE; CARBONATED
Related Searches:
ORANGEDEX 100
GLUCOSE TEST SOLUTION
NSN, MFG P/N
6505010878516
NSN
6505-01-087-8516
MFG
CUSTOM LABORATORIES INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 100.000 GRAMS DEXTROSE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
FLAVOR: ORANGE
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 FLUID OUNCES
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: CAFFEINE FREE; CARBONATED
Related Searches:
NDC00074-1523-02
DEXTROSE INJECTION,MODIFIED
NSN, MFG P/N
6505010879039
NSN
6505-01-087-9039
NDC00074-1523-02
DEXTROSE INJECTION,MODIFIED
NSN, MFG P/N
6505010879039
NSN
6505-01-087-9039
MFG
ABBOTT LABORATORIES INC. DIV HOSPITAL PRODUCTS DIVISION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 PERCENTAGE, W/V DEXTROSE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: PARTIAL FILL 100 ML IN 300 ML VIAL;WATER FILLER
Related Searches:
7068
CEFAMANDOLE NAFATE FOR INJECTION,USP
NSN, MFG P/N
6505010879592
NSN
6505-01-087-9592
7068
CEFAMANDOLE NAFATE FOR INJECTION,USP
NSN, MFG P/N
6505010879592
NSN
6505-01-087-9592
MFG
ELI LILLY AND COMPANY DBA ELI LILLY
Description
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: EQUIVALENT TO 1 GM. CEFAMANDOLE
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: 100 ML. SIZE VIAL
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
MANDOL
CEFAMANDOLE NAFATE FOR INJECTION,USP
NSN, MFG P/N
6505010879592
NSN
6505-01-087-9592
MANDOL
CEFAMANDOLE NAFATE FOR INJECTION,USP
NSN, MFG P/N
6505010879592
NSN
6505-01-087-9592
MFG
ELI LILLY AND COMPANY DBA ELI LILLY
Description
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: EQUIVALENT TO 1 GM. CEFAMANDOLE
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: 100 ML. SIZE VIAL
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
NDC00002-7068-10
CEFAMANDOLE NAFATE FOR INJECTION,USP
NSN, MFG P/N
6505010879592
NSN
6505-01-087-9592
NDC00002-7068-10
CEFAMANDOLE NAFATE FOR INJECTION,USP
NSN, MFG P/N
6505010879592
NSN
6505-01-087-9592
MFG
ELI LILLY AND COMPANY DBA ELI LILLY
Description
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: EQUIVALENT TO 1 GM. CEFAMANDOLE
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: 100 ML. SIZE VIAL
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
ATIVAN
LORAZEPAM TABLETS,USP
NSN, MFG P/N
6505010879807
NSN
6505-01-087-9807
MFG
AMERICAN HOME PRODUCTS CORP WYETH-AYERST LABORATORIES DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.000 MILLIGRAMS LORAZEPAM ACTIVE INGREDIENT
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00008-0065-03
LORAZEPAM TABLETS,USP
NSN, MFG P/N
6505010879807
NSN
6505-01-087-9807
NDC00008-0065-03
LORAZEPAM TABLETS,USP
NSN, MFG P/N
6505010879807
NSN
6505-01-087-9807
MFG
AMERICAN HOME PRODUCTS CORP WYETH-AYERST LABORATORIES DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.000 MILLIGRAMS LORAZEPAM ACTIVE INGREDIENT
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00469-0268-25
SCOPOLAMINE HYDROBROMIDE INJECTION,USP
NSN, MFG P/N
6505010880499
NSN
6505-01-088-0499
NDC00469-0268-25
SCOPOLAMINE HYDROBROMIDE INJECTION,USP
NSN, MFG P/N
6505010880499
NSN
6505-01-088-0499
MFG
LYPHOMED INC DIV OF FUJISAWA USA INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.400 MILLIGRAMS SCOPOLAMINE HYDROBROMIDE PER MILLILITER
III PART NAME ASSIGNED BY CONTROLLING AGENCY: SCOPOLAMINE HYDROBROMIDE INJECTION USP 0.4MG/ML 1ML VIAL 25 PER BX
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
III SUPPLEMENTARY FEATURES: D-DAY ITEM FOR DOD
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 MILLILITERS
PRIMARY CONTAINER TYPE: ANY ACCEPTABLE
TOTAL PRIMARY CONTAINER QUANTITY: 25
Related Searches:
NDC63323-0268-01
SCOPOLAMINE HYDROBROMIDE INJECTION,USP
NSN, MFG P/N
6505010880499
NSN
6505-01-088-0499
NDC63323-0268-01
SCOPOLAMINE HYDROBROMIDE INJECTION,USP
NSN, MFG P/N
6505010880499
NSN
6505-01-088-0499
MFG
VETERANS HEALTH
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.400 MILLIGRAMS SCOPOLAMINE HYDROBROMIDE PER MILLILITER
III PART NAME ASSIGNED BY CONTROLLING AGENCY: SCOPOLAMINE HYDROBROMIDE INJECTION USP 0.4MG/ML 1ML VIAL 25 PER BX
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
III SUPPLEMENTARY FEATURES: D-DAY ITEM FOR DOD
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 MILLILITERS
PRIMARY CONTAINER TYPE: ANY ACCEPTABLE
TOTAL PRIMARY CONTAINER QUANTITY: 25
Related Searches:
4903-01
LIDOCAINE HYDROCHLORIDE INJECTION,USP
NSN, MFG P/N
6505010880500
NSN
6505-01-088-0500
4903-01
LIDOCAINE HYDROCHLORIDE INJECTION,USP
NSN, MFG P/N
6505010880500
NSN
6505-01-088-0500
MFG
ABBOTT LABORATORIES INC. DIV HOSPITAL PRODUCTS DIVISION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.000 PERCENTAGE, W/V LIDOCAINE HYDROCHLORIDE ACTIVE INGREDIENT
ADMINISTRATION: INTRAVENOUS
PRIMARY CONTAINER CONTENT QUANTITY: 5.000 MILLILITERS
PRIMARY CONTAINER TYPE: SYRINGE-NEEDLE UNIT
SPECIAL FEATURES: NEEDLE SIZE 21 GAGE BY 1-1/2 INCHES
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
NDC00074-4903-01
LIDOCAINE HYDROCHLORIDE INJECTION,USP
NSN, MFG P/N
6505010880500
NSN
6505-01-088-0500
NDC00074-4903-01
LIDOCAINE HYDROCHLORIDE INJECTION,USP
NSN, MFG P/N
6505010880500
NSN
6505-01-088-0500
MFG
ABBOTT LABORATORIES INC. DIV HOSPITAL PRODUCTS DIVISION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.000 PERCENTAGE, W/V LIDOCAINE HYDROCHLORIDE ACTIVE INGREDIENT
ADMINISTRATION: INTRAVENOUS
PRIMARY CONTAINER CONTENT QUANTITY: 5.000 MILLILITERS
PRIMARY CONTAINER TYPE: SYRINGE-NEEDLE UNIT
SPECIAL FEATURES: NEEDLE SIZE 21 GAGE BY 1-1/2 INCHES
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
10-20
GENTAMICIN SULFATE INJECTION,USP
NSN, MFG P/N
6505010883692
NSN
6505-01-088-3692
10-20
GENTAMICIN SULFATE INJECTION,USP
NSN, MFG P/N
6505010883692
NSN
6505-01-088-3692
MFG
LYPHOMED INC DIV OF FUJISAWA USA INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 40.000 MILLIGRAMS GENTAMICIN EQUIVALENT PER MILLILITER
ADMINISTRATION: INTRAMUSCULAR OR INTRAVENOUS
PRIMARY CONTAINER CONTENT QUANTITY: 20.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
Related Searches:
GARAMYCIN
GENTAMICIN SULFATE INJECTION,USP
NSN, MFG P/N
6505010883692
NSN
6505-01-088-3692
GARAMYCIN
GENTAMICIN SULFATE INJECTION,USP
NSN, MFG P/N
6505010883692
NSN
6505-01-088-3692
MFG
SCHERING CORP AN AFFIL OF SCHERING-PLOUGH CORP
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 40.000 MILLIGRAMS GENTAMICIN EQUIVALENT PER MILLILITER
ADMINISTRATION: INTRAMUSCULAR OR INTRAVENOUS
PRIMARY CONTAINER CONTENT QUANTITY: 20.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
Related Searches:
NDC00085-0069-08
GENTAMICIN SULFATE INJECTION,USP
NSN, MFG P/N
6505010883692
NSN
6505-01-088-3692
NDC00085-0069-08
GENTAMICIN SULFATE INJECTION,USP
NSN, MFG P/N
6505010883692
NSN
6505-01-088-3692
MFG
SCHERING CORP AN AFFIL OF SCHERING-PLOUGH CORP
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 40.000 MILLIGRAMS GENTAMICIN EQUIVALENT PER MILLILITER
ADMINISTRATION: INTRAMUSCULAR OR INTRAVENOUS
PRIMARY CONTAINER CONTENT QUANTITY: 20.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
Related Searches:
NDC00469-1000-40
GENTAMICIN SULFATE INJECTION,USP
NSN, MFG P/N
6505010883692
NSN
6505-01-088-3692
NDC00469-1000-40
GENTAMICIN SULFATE INJECTION,USP
NSN, MFG P/N
6505010883692
NSN
6505-01-088-3692
MFG
LYPHOMED INC DIV OF FUJISAWA USA INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 40.000 MILLIGRAMS GENTAMICIN EQUIVALENT PER MILLILITER
ADMINISTRATION: INTRAMUSCULAR OR INTRAVENOUS
PRIMARY CONTAINER CONTENT QUANTITY: 20.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
Related Searches:
NDC00548-6534-00
GENTAMICIN SULFATE INJECTION,USP
NSN, MFG P/N
6505010883692
NSN
6505-01-088-3692
NDC00548-6534-00
GENTAMICIN SULFATE INJECTION,USP
NSN, MFG P/N
6505010883692
NSN
6505-01-088-3692
MFG
INTERNATIONAL MEDICATION SYSTEMS LTD.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 40.000 MILLIGRAMS GENTAMICIN EQUIVALENT PER MILLILITER
ADMINISTRATION: INTRAMUSCULAR OR INTRAVENOUS
PRIMARY CONTAINER CONTENT QUANTITY: 20.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
Related Searches:
NDC00641-2331-41
GENTAMICIN SULFATE INJECTION,USP
NSN, MFG P/N
6505010883692
NSN
6505-01-088-3692
NDC00641-2331-41
GENTAMICIN SULFATE INJECTION,USP
NSN, MFG P/N
6505010883692
NSN
6505-01-088-3692
MFG
ELKINS-SINN INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 40.000 MILLIGRAMS GENTAMICIN EQUIVALENT PER MILLILITER
ADMINISTRATION: INTRAMUSCULAR OR INTRAVENOUS
PRIMARY CONTAINER CONTENT QUANTITY: 20.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
Related Searches:
NDC00456-0321-01
LEVOTHYROXINE SODIUM TABLETS,USP
NSN, MFG P/N
6505010884252
NSN
6505-01-088-4252
NDC00456-0321-01
LEVOTHYROXINE SODIUM TABLETS,USP
NSN, MFG P/N
6505010884252
NSN
6505-01-088-4252
MFG
FOREST PHARMACEUTICALS INC SUB OF FOREST LABORATORIES INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.050 MILLIGRAMS LEVOTHYROXINE SODIUM ACTIVE INGREDIENT
DESIGN CONTROL REFERENCE: NDC00456-0321-01
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LEVOTHYROXINE SODIUM TABLETS USP 100S BT
MANUFACTURERS CODE: 65050
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: SOLE SOURCE ITEM FOR DOD, LEVOTHROID MFR BY RHONE-POULENC RORER FOR FOREST
THE MANUFACTURERS DATA:
